Start » Department of Cardiovascular Surgery » Coronary bypass surgery » Complications of myocardial infarction

Mechanical complications after acute myocardial infarction

The typical five mechanical complications after myocardial infarction include:

 

  1. Acute mitral valve insufficiency due to papillary muscle rupture (partial or complete rupture)
  2. Ventricular septal defect
  3. Rupture of the free myocardial wall with consecutive pericardial tamponade
  4. Pseudoaneurysm of the left ventricle
  5. Ventricular aneurysm of the left ventricle

 

The first four complications mentioned are especially associated with high morbidity and lethality. Successful management of these complications is highly complex and requires excellent multidisciplinary collaboration between cardiac surgeons, cardiologists and intensive care physicians, as well as the relevant nursing staff. The typical patient presenting with mechanical complications after myocardial infarction is the elderly woman with heart failure and chronic renal failure who developed her first myocardial infarction in the process. On admission to hospital, these patients are often already in cardiogenic shock with a high catecholamine or vasopressor requirement and not infrequently already intubated and mechanically ventilated. The five typical mechanical complications with their incidence, pathophysiology, clinical presentation, course and therapy are discussed in detail below.

Acute mitral valve regurgitation with papillary muscle rupture (partial or complete)

The incidence of acute mitral regurgitation due to partial or complete papillary muscle rupture after myocardial infarction is 0.05 to 0.26 per cent and is associated with a lethality of 10 to 40 per cent. If, in the course of a myocardial infarction, there is a reduction in blood flow or a complete interruption of blood flow to the papillary muscles, rupture may occur. The posteromedial papillary muscle is more frequently affected because, unlike the anterolateral papillary muscle, it is supplied by only one coronary vessel, either the circumflex branch or the right coronary artery. The severity of the patient’s clinical symptoms is determined by whether the papillary muscle is partially or completely torn off. Patients with acute mitral regurgitation typically present with acute pulmonary oedema 3 to 5 days after acute transmural ST elevation myocardial infarction. After appropriate diagnostics, primarily by means of echocardiography, and intensive medical stabilisation, there is an indication for emergency mitral valve replacement, either biological or mechanical. The affected coronary arteries are often supplied with bypasses. The perioperative lethality in this case is about 20 per cent. The survival rate after surgical intervention is over 70 per cent, whereas the survival rate after conservative, medicinal and intensive medical therapy alone is only 30 per cent. Alternatively, for patients who cannot undergo cardiac surgery, an interventional therapy strategy using MitraClip as a so-called “edge-to-edge repair” can be considered.

Ventricular septal defect after myocardial infarction

The incidence of ventricular septal defect (VSD) after acute myocardial infarction is 0.3 per cent. Risk factors are increased age, female gender and delayed therapy of myocardial infarction. In 70 per cent of cases, so-called apical or anterior ventricular septal defects occur, in which the left anterior descending artery is affected as the supplying vessel. Posterior VSDs with the right coronary artery as the supplying vessel are present in 30 per cent. The lethality of untreated VSD is 80 per cent in the first 30 days after myocardial infarction. Patients typically present 3 to 5 days after myocardial infarction with dyspnoea, orthopnoea, hypotension, oliguria and cold periphery due to the more or less pronounced left-to-right shunt. After appropriate diagnostics by means of echocardiography, the patient is stabilised in intensive care. The treatment of choice is surgical closure of the VSD using a patch. In this case, the procedure is delayed by 7 days in haemodynamically stable patients under intensive medical supervision until  the adjacent tissue has stabilised by means of connective and scar tissue. The surgical techniques used are either a Daggett patch repair or a David infarct exclusion, possibly with concomitant bypass. Emergency surgery is only considered in haemodynamically unstable patients in refractory cardiogenic shock and is associated with a high concomitant lethality. Alternatively, interventional treatment with an Amplatzer® Septal Occluder Device can be considered.  Although the initial success rate is very high at 80 to 100 per cent, complications such as embolisation of the occluder device, device failure in the sense of insufficient closure of the VSD or ventricular arrhythmias and haemolysis frequently occur during the course of the procedure.

Myocardial wall rupture with consecutive pericardial tamponade

Rupture of the free myocardial wall after myocardial infarction leads to pericardial tamponade in a very short time. The true incidence of free myocardial wall rupture is therefore unclear, as this event often occurs outside a hospital as what is termed a sudden cardiac death. When this event occurs in hospital, the affected patient will show jugular dilation, pulsus paradoxus, attenuated heart sounds and ultimately pulseless electrical activity, known as electro-mechanical uncoupling. The diagnostic tool of choice is echocardiography.  Care is emergency surgical haematoma decompression with infarctomy and patch closure of the defect using Dacron or pericardial patches. The in-hospital mortality rate is about 35 per cent. Following surgery, mechanical decompression of the left ventricle using extracorporeal membrane oxygenation (ECMO), interventional Impella CP® device or left ventricular assist device (LVAD) is often recommended.

Pseudoaneurysm of the left ventricle after myocardial infarction

Pseudoaneurysms of the left ventricle are very rare and are a special form of the previously mentioned rupture of the free ventricular wall. This is a covered perforation of the ventricular wall. If, after transmural myocardial infarction, adhesions and malformations of the epicardium with the adjacent pericardium occur in the context of the accompanying inflammatory reactions, the pericardium adhered as a result prevents blood from escaping from the left ventricle in the area of the rupture of the ventricular wall.  Pseudoaneurysms are most common in the lateral and posterior wall of the left ventricle. This can be explained by the recumbent position of patients hospitalised for myocardial infarction.  The clinical symptoms are often non-specific, so that a pseudoaneurysm can often remain undetected for a long time. Symptoms include dyspnoea, signs of heart failure and chest pain. This complication affects men more often than women. The diagnostic tools are echocardiography, computed tomography and magnetic resonance imaging. Treatment is urgent surgical closure of the perforation site using PTFE reinforced direct suture or Gore-Tex, Dacron or pericardial patch closure. Alternatively, arterial retrograde interventional closure with an Amplatzer® Septal Occluder Device is possible in inoperable patients . Placement is carried out under transoesophageal echocardiography and fluoroscopy control.

Aneurysm of the left ventricle after myocardial infarction

True aneurysms of the left ventricle after myocardial infarction can remain undetected for a long time. Surgical therapy is considered for refractory heart failure, ventricular arrhythmias that persist with maximal pharmacological therapy and after interventional ablation attempts, and recurrent thromboembolism from the aneurysm despite effective anticoagulation therapy. Here, there is a IIa recommendation according to the American College of Cardiologists (ACC) and the American Heart Association (AHA) of 2004, with an evidence level B. Surgical treatment consists of plication or excision of the aneurysm with concomitant reconstruction of the left ventricle using endoventricular patches.